| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |